FDA gives the OK to Siemens' linear accelerator

TriMed Staff | | Health Imaging | Screening
Siemens Medical Solutions USA Inc. has received FDA 510(k) clearance for its Oncor Avant-Garde linear accelerator.

Oncor integrates with technologies, such as the Optifocus MLC, a full-field, high-resolution multileaf collimator, and the Optivue amorphous silicon, flat-panel imaging system. The system also incorporates Siemens' Optibeam IMRT, an optimized technique for intensity modulated radiation therapy delivery that uses verification to safely provide treatments with speed and accuracy.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Cardiovascular Business
COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke

These risks appear to be present regardless of a person's age or health at the time of infection.

Radiology Business
Top performing PACS companies based on user feedback

Agfa and Sectra both performed well with end-user satisfaction scores in the 2025 Best in KLAS list of radiology IT systems.